WASHINGTON, March 30, 2016 -- A report was released today about Bisphenol A (BPA) and its presence in food can linings. The International Food Information Council (IFIC) Foundation published a review on BPA and the science behind the headlines.
The world's top food safety authorities, including both the U.S. Food and Drug Administration and the European Food Safety Authority (EFSA), have reviewed extensive science around BPA and confirmed repeatedly that there is zero threat to human health and safety.
BPA (and any substitutes) are used in can liners because, without a liner, metal cans get corroded or punctured. This increases the risk of foodborne illness. Packaging serves an important food safety function – it protects food from contaminants and keeps food fresh.
Additional IFIC Foundation Resources on BPA:
War on Food Science: Part 2 – Bisphenol-A (BPA)
News Bite: FDA Reaffirms Safety of Bisphenol-A
Questions and Answers About Bisphenol-A (BPA)
If you have additional questions, please contact Laura Kubitz ([email protected]) or Matt Raymond ([email protected]).
The International Food Information Council Foundation is dedicated to the mission of effectively communicating science-based information on health, food safety and nutrition for the public good. The IFIC Foundation is supported primarily by the broad-based food, beverage and agricultural industries. Visit http://www.foodinsight.org.
CONTACT: Matt Raymond ([email protected]) Laura Kubitz ([email protected])


ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 



